InduPro raises $77.0M Series B (United States, Aug 2026)
Reach the investors backing rounds like this
Backed by The Column Group, Vida Ventures +6 more · verified emails and LinkedIn on Datapile
Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline - The Business Journals
InduPro is a biotechnology company focused on defining membrane protein spatial relationships to create novel therapeutics for cancer and autoimmune diseases. The company is advancing its lead oncology program, IDP-001, which is currently in a Phase 1 clinical study targeting advanced squamous non-small cell lung cancer and other solid tumors. This funding round will support the clinical development and proof-of-concept data generation for IDP-001.
Seattle biotech InduPro raises $77 million to advance cancer treatment pipeline The Business Journals
20,207 investors back startups in United States
You just read who funded InduPro. The same database has the investors behind every other round — with verified emails, check sizes and the stages they actually write at.
Free account: 5 investor contact unlocks a month, no card required.